Literature DB >> 8601737

Fibronectin degradation in chronic wounds depends on the relative levels of elastase, alpha1-proteinase inhibitor, and alpha2-macroglobulin.

F Grinnell1, M Zhu.   

Abstract

The goal of our studies was to learn about the mechanism of fibronectin degradation in chronic ulcers. We found that the appearance of fibronectin fragments in chronic ulcer wound fluid correlated with elevated levels of elastase and cleavage of the proteinase inhibitors alpha2-macroglobulin (alpha2-M) and alpha 1-proteinase inhibitor (alpha1-P1). Some wound fluid samples retained the capacity to degrade fibronectin in vitro. Degradation of fibronectin by these samples was blocked by specific inhibitors of neutrophil elastase but not by inhibitors of metalloproteinases. Addition of human neutrophil elastase to mastectomy fluid, an acute wound fluid, resulted in formation of alpha1-PI and alpha2-M complexes and cleavage products resembling those observed in chronic wound fluid. Moreover, degradation of fibronectin and processing of matrix metalloproteinase MMP-9 occurred under these conditions. Taken together, our findings suggest that elevated levels of neutrophil elastase are responsible for fibronectin degradation in the chronic wound environment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8601737     DOI: 10.1111/1523-1747.ep12342990

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  41 in total

1.  Efficacy of glutathione mesotherapy in burns: an experimental study.

Authors:  A Buz; T Görgülü; A Olgun; E Kargi
Journal:  Eur J Trauma Emerg Surg       Date:  2015-11-27       Impact factor: 3.693

Review 2.  Gene therapy and wound healing.

Authors:  Sabine A Eming; Thomas Krieg; Jeffrey M Davidson
Journal:  Clin Dermatol       Date:  2007 Jan-Feb       Impact factor: 3.541

Review 3.  [Chronic wounds. Novel approaches in research and therapy].

Authors:  S A Eming; J Kaufmann; R Löhrer; T Krieg
Journal:  Hautarzt       Date:  2007-11       Impact factor: 0.751

4.  Alternative proteolytic processing of hepatocyte growth factor during wound repair.

Authors:  Nils Buchstein; Daniel Hoffmann; Hans Smola; Sabina Lang; Mats Paulsson; Catherin Niemann; Thomas Krieg; Sabine A Eming
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

Review 5.  Vacuum-assisted closure home care training: a process to link education to improved patient outcomes.

Authors:  Kevin Y Woo; R Gary Sibbald
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

Review 6.  The Effect of pH on the Extracellular Matrix and Biofilms.

Authors:  Eleri M Jones; Christine A Cochrane; Steven L Percival
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-07-01       Impact factor: 4.730

7.  Ovine forestomach matrix biomaterial is a broad spectrum inhibitor of matrix metalloproteinases and neutrophil elastase.

Authors:  Leonardo Negron; Stan Lun; Barnaby C H May
Journal:  Int Wound J       Date:  2012-11-01       Impact factor: 3.315

8.  Fibronectin fragmentation is a feature of periodontal disease sites and diabetic foot and leg wounds and modifies cell behavior.

Authors:  Corey M Stanley; Yao Wang; Sanjay Pal; Robert J Klebe; Lawrence B Harkless; Xiaoping Xu; Zhihua Chen; Bjorn Steffensen
Journal:  J Periodontol       Date:  2008-05       Impact factor: 6.993

Review 9.  Biologic therapeutics and molecular profiling to optimize wound healing.

Authors:  Marie N Menke; Nathan B Menke; Cecelia H Boardman; Robert F Diegelmann
Journal:  Gynecol Oncol       Date:  2008-10-01       Impact factor: 5.482

10.  Factor XII and uPAR upregulate neutrophil functions to influence wound healing.

Authors:  Evi X Stavrou; Chao Fang; Kara L Bane; Andy T Long; Clément Naudin; Erdem Kucukal; Agharnan Gandhi; Adina Brett-Morris; Michele M Mumaw; Sudeh Izadmehr; Alona Merkulova; Cindy C Reynolds; Omar Alhalabi; Lalitha Nayak; Wen-Mei Yu; Cheng-Kui Qu; Howard J Meyerson; George R Dubyak; Umut A Gurkan; Marvin T Nieman; Anirban Sen Gupta; Thomas Renné; Alvin H Schmaier
Journal:  J Clin Invest       Date:  2018-01-29       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.